A feasible protocol to profile bile acids in dried blood spots from rats using a UHPLC-MS/MS method combining a surrogate matrix
The Analyst · 2023
DOI: 10.1039/d3an00900a ↗Kurz gefasst
Studienprotokoll in der Zeitschrift The Analyst, 2023. Verfasst von Ziying Ma und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College & Chinese Ac…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Bile Acids and Salts. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A two-step method was applied to enable high extraction efficiency for bile acids in DBSs. A DBS surrogate matrix was well developed and showed good performance, and 35 bile acids were profiled using UHPLC-MS/MS with good resolution and quantified with acceptable precision and accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, PR China. zhjl@imm.ac.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ma, Z., Sheng, N., & Zhang, J. (2023). A feasible protocol to profile bile acids in dried blood spots from rats using a UHPLC-MS/MS method combining a surrogate matrix. The Analyst. https://doi.org/10.1039/d3an00900a
Vancouver
Ma Z, Sheng N, Zhang J. A feasible protocol to profile bile acids in dried blood spots from rats using a UHPLC-MS/MS method combining a surrogate matrix. The Analyst. 2023. doi:10.1039/d3an00900a
BibTeX
@article{Ma2023,
author = {Ma, Ziying and Sheng, Ning and Zhang, Jinlan},
title = {A feasible protocol to profile bile acids in dried blood spots from rats using a UHPLC-MS/MS method combining a surrogate matrix},
journal = {The Analyst},
year = {2023},
doi = {10.1039/d3an00900a}
}
EUVIMED